The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world use of accelerated approval oncology drugs subsequently withdrawn in the United States.
 
Francesca Coutinho
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb/Celgene (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); SERVIER (Inst)
 
Aliza Karpes-Matusevich
Research Funding - Astellas Oncology (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Johnson & Johnson (Inst); Novartis (Inst); Taiho Oncology (Inst)
 
Vincent Miller
Research Funding - BeiGene (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Regeneron (Inst)